Company: CWAN
Filing Date: 2025-03-06
Form Type: S-4/A
Source: 0001193125-25-048570
Chunk: 6

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-06
Form: S-4/A
Chunk 6
---
 and the other transactions contemplated by the Merger Agreement are advisable, fair to and in the best interests of Enfusion and Enfusion Stockholders, and
(b) recommended that the Enfusion Stockholders adopt the Merger Agreement and approve the transactions contemplated by the Merger Agreement,

including the Mergers, (iii) recommended that the Enfusion Board adopt a resolution recommending that the Enfusion Stockholders vote their shares in favor of adopting the Merger Agreement at
a special meeting of the Enfusion Stockholders.

The Enfusion Board (acting on the unanimous recommendation of the Special Committee)
unanimously (i) determined that the Merger Agreement, the Mergers and the other transactions contemplated by the Merger Agreement are advisable, fair to and in the best interests of Enfusion and Enfusion Stockholders, (ii) adopted and
approved the Merger Agreement, the Mergers and the other transactions contemplated by the Merger Agreement, (iii) directed that the Merger Agreement be submitted to Enfusion Stockholders entitled to vote thereon for adoption thereby and
(iv) resolved to recommend that such stockholders adopt the Merger Agreement and approve the transactions contemplated by the Merger Agreement, including the Mergers.

In connection with the proposed Mergers, Enfusion will hold a special meeting of its stockholders (the “”). At
the Special Meeting, Enfusion Stockholders will be asked to vote on (i) a proposal to adopt the Merger Agreement (the “”) and (ii) a proposal to approve one or more adjournments of the Special
Meeting, if necessary or appropriate, to permit solicitation of additional votes or proxies if there are not sufficient votes to approve the Merger Agreement Proposal (the “”). Approval of the Merger Agreement
Proposal requires the affirmative vote of the holders of a majority of Enfusion Common Stock and Enfusion Class B Common Stock outstanding entitled to vote thereon, and approval of the Adjournment Proposal requires the affirmative vote of the
holders of a majority of the votes cast affirmatively and negatively on the applicable proposal, assuming a quorum is present. The Special Meeting will be held virtually via live audio webcast at , on
, 2025, at Eastern Time. The board of directors of Enfusion unanimously recommends that stockholders of Enfusion vote (i)“FOR”the Merger Agreement Proposal and (ii)“FOR”the Adjournment Proposal.

Your vote is very important.The obligations of Enfusion and Clearwater to complete the